Link copied!
Indications
For the dietary management of:
- Disease-related malnutrition.
- Patients with reduced energy requirements (e.g. patients who are immobile and/or have a severe neurological disorder).
Important Notice
- Not for parenteral use.
- Not suitable for patients requiring a fibre free diet.
- Not suitable for patients with galactosaemia.
- Not suitable for patients with cow’s milk protein allergy.
- Not suitable for infants and children under 6 years of age.
- Use with caution in children aged 6-12 years of age.
- Use with caution in individuals with a seafood allergy.
- Weight loss and protein intake must be monitored.
- Monitor hydration status.
- Must be used under medical supervision.
Direction for Use
- Check appearance before use and shake well.
- Use at room temperature.
- Handle aseptically to ensure product remains sterile.
- Usage to be determined by a healthcare professional.
- Do not dilute or add medications to the formula.
Storage
- Store in a cool, dry place.
- Once opened, close the bottle and store in the refrigerator.
- Discard unused content after 24 hours.
Order Information
Contact Nutricia Customer Experience 0800 688 747
Nutrison 800 Complete Multi Fibre | Product Code | Units per carton | Pharmacode |
1000ml OpTri bottle | 132379 | 8 | 2572982 |
Ingredients
Full ingredients list and nutritional information is available on the product fact sheet.
Allergen & Cultural Information
- Contains: milk, soy and fish.
- Halal certified.
- Nutricia UK and/or Ireland have Kosher approval for this product.
- No gluten containing ingredients. No detectable gluten when tested to a sensitivity level of less than 5 parts per million (<5 ppm i.e. <5mg/kg).
- Low lactose (lactose < 2g/100g).
References
- Dickerson RN et al. Measured energy expenditure of tube-fed patients with severe neurodevelopmental disabilities. J Am Coll Nutr. 1999 Feb;18(1):61-8.
- Dickerson RN et al. Energy requirements of non-ambulatory, tube-fed adult patients with cerebral palsy and chronic hypothermia. Nutrition. 2003 Sep;19(9):741-6.
- Dickerson RN et al. Validation of a new method for estimating resting energy expenditure of non-ambulatory tube-fed patients with severe neurodevelopmental disabilities. Nutrition. 2002 Jul-Aug;18(7-8):578-82.
- Hurt RT, McClave SA, Martindale RG, et al. Summary Points and Consensus Recommendations From the International Protein Summit. Nutrition in Clinical Practice. 2017;32:142S–151S.
- World Health Organization. Protein and amino acid requirements in human nutrition: report of a joint FAO/WHO/UNU expert consultation. 2007; WHO technical report series ; no. 935.
- Kuyumcu S, Menne D, Curcic J, et al. Noncoagulating enteral formula can empty faster from the stomach: A double-blind, randomized crossover trial using magnetic resonance imaging. Journal of Parenteral and Enteral Nutrition. 2015;39:544-551.
- van den Braak CC, Klebach M, Abrahamse E, et al. A novel protein mixture containing vegetable proteins renders enteral nutrition products non-coagulating after in vitro gastric digestion. Clinical Nutrition. 2013;32:765-771.
- Klebach M, Hofman Z, Bluemel S, et al. Effect of protein type in enteral nutritionformulas on coagulation in the stomach in vivo: Post hoc analyses of a randomized controlled trial with MRI. Abstract presented at Clinical Nutrition Week, January 16–19; Austin, Tx. Journal of Parenteral and Enteral Nutrition. 2016;40:134(21).
- Luttikhold J, van Norren K, Rijna H, et al. Jejunal feeding is followed by a greater rise in plasma cholecystokinin, peptide YY, glucagon-like peptide 1, and glucagon-like peptide 2 concentrations compared with gastric feeding in vivo in humans: a randomized trial. Am J Clin Nutr. 2016;103:435–43.
- Abrahamse E, van der Lee S, van den Braak S, et al. Gastric non-coagulation of enteral tube feed yields faster gastric emptying of protein in a dynamic in vitro model. Abstract presented at 34th ESPEN Congress. Sept 8-11; Barcelona, Spain. Clinical Nutrition Supplements. 2012;7:PP239(119).
- Liu J, Klebach M, Abrahamse E, et al. Specific protein mixture reduces coagulation: An in vitro stomach model study mimicking a gastric condition in critically ill patients. Poster presented at 38th ESPEN Congress. 17-20 September; Copenhagen, Denmark. Clinical Nutrition. 2016;35:MON-P182 (S220).
Additional Information
^ In accordance with Australia New Zealand Food Standards Code – Standard 2.9.5
# MF6 is a unique, patented blend of six soluble and insoluble fibres (soy polysaccharide, cellulose, resistant starch, gum arabic, oligofructose and inulin) reflecting the proportions of the different fibre types in a healthy diet.